Actually AGN was around $50m 2 years ago. Two and a half years ago it spiked to nearly $100m for a brief period.
NYR was $30m 2 years ago and nearly $70m 3 years ago.
AGN has continued to range between $40m and $85m for the last couple of years. That's actually not bad given the overall trend for the biotech sector - see previous post for reasons why AGN SP has done OK (compared to NYR).
NYR Price at posting:
6.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)